DVA Medicinal Cannabis Changes: What Veterans Must Do Before 31 August 2026

If DVA funds your medicinal cannabis, the arrangements that kept your existing script running end on 31 August 2026. After that date, continued funding depends on your prescription meeting DVA’s updated Medicinal Cannabis Framework. If you do nothing and your prescriber does nothing, you risk your funded treatment stopping. This article explains what is changing, who it affects, and the steps to take before the deadline.

What is actually changing

DVA has updated its Medicinal Cannabis Framework, which sets out how it funds medicinal cannabis for veterans. The updated framework took effect on 16 February 2026. When it came in, DVA put transitional arrangements in place, often called grandfathering, for veterans who already had a DVA-funded script dispensed between 16 February 2025 and 15 February 2026, so they were not cut off overnight. Those transitional arrangements end on 31 August 2026.

From 1 September 2026, DVA expects every funded prescription to sit within the updated framework rather than the old transitional allowance. The temporary bridge that let existing scripts keep running is being removed, and everyone needs to be on the current pathway.

DVA has flagged this directly. It has published a veteran-facing factsheet and FAQ, put a matching notice on its provider-news page for prescribers, and treating clinics have been contacting affected patients. The message across all three is the same: sort it out before 31 August.

What the updated framework requires

Under the updated framework, a DVA-funded medicinal cannabis prescription has to meet a tighter set of rules. Based on DVA’s own framework guidance, the main requirements are:

• Your prescriber must hold specialist registration with the Australian Health Practitioner Regulation Agency (Ahpra).
• Initial consultations for new clients must be done in person rather than by telehealth, along with any change that moves you from Tier 1 to Tier 2 treatment, or a change of prescriber.
• DVA funds dried herb medicinal cannabis for vaporisation using a device approved by the Therapeutic Goods Administration (TGA), as well as oral capsules and liquids.
• The product must have a THC concentration of 25% or less, with a total of 2 grams of dried herb per day or less across all products, and no more than three products.
• Standard evidence-based treatments for your condition must have been tried and have not worked.
• A suicide and mental health assessment is part of the process, and must be documented.

One point worth being precise about: if you are already established with an Ahpra-compliant prescriber under a DVA-funded script, you do not need a new in-person visit purely because the transitional arrangements are ending. The in-person requirement is about how you get onto or move within the framework, not a blanket rule that everyone must attend a fresh appointment by 31 August.

These are the details your prescriber needs to work through with you. You do not have to memorise them, but knowing they exist helps you ask the right question.

Who this affects

This matters to you if DVA currently pays for your medicinal cannabis, whether that is for chronic pain, sleep problems, or another accepted condition, and your prescription was set up under the earlier arrangements.

It does not change whether medicinal cannabis is clinically right for you. That is a decision for you and your treating doctor. What is changing is the basis DVA uses to keep funding it. If your script already meets the updated framework, you may not need to do anything. If it is running on the transitional arrangement, you are the one on the clock.

What you need to do before 31 August 2026

The single most useful step is to talk to your prescriber now, not in the last week of August. Ask them one direct question: is my DVA-funded medicinal cannabis prescription compliant with DVA’s updated Medicinal Cannabis Framework, or am I still relying on the transitional arrangement?

If you are still on the transitional arrangement, your prescriber needs to move you onto the updated pathway, which may mean a referral to an Ahpra-registered specialist prescriber, an in-person appointment, and a change of product to meet the THC and quantity limits. Book the appointment early. Prescribers are managing this change across many patients at once, and in-person specialist appointments get harder to find as a deadline approaches.

Keep a copy of anything DVA has sent you about the change, including the factsheet, and bring it to the appointment so your prescriber can see exactly what DVA is asking for.

What happens if you miss the deadline

If the transitional arrangement ends and your script has not been brought onto the updated framework, the practical risk is an interruption to funded treatment. That can mean paying out of pocket to continue, or a gap while a compliant prescription is put in place. For a treatment you rely on for pain or sleep, even a short gap is disruptive.

None of that is automatic or punitive. It is a prescribing and paperwork step that needs to happen in time. The veterans who get caught out are usually the ones who left it too late to get an appointment, not the ones who were refused.

How this fits the bigger DVA treatment picture

Medicinal cannabis funding sits inside DVA’s broader treatment system, which runs through your health card. How your treatment is paid for depends on whether you hold a DVA White Card for accepted conditions or a Gold Card for all clinically necessary care.

This change also lands during a period of steady tightening in how DVA funds treatment, with provider integrity a stated priority. The direction is clear: DVA wants funded treatment to sit cleanly within its frameworks. Staying inside the rules is what keeps your funding secure.

Frequently asked questions

When do the DVA medicinal cannabis grandfathering arrangements end?

The transitional (grandfathering) arrangements for existing DVA-funded medicinal cannabis prescriptions end on 31 August 2026. From 1 September 2026, continued DVA funding requires a prescription that meets DVA’s updated Medicinal Cannabis Framework.

Will my DVA-funded medicinal cannabis stop on 31 August 2026?

Not automatically, but the risk is real if your prescription is still running on the old transitional arrangement and has not been moved onto the updated framework. The way to avoid a gap is to have your prescriber confirm your script is compliant before the deadline.

What does the updated framework require?

In short: a prescriber with specialist Ahpra registration, an in-person visit for new clients (or for a change of prescriber or a move to a higher treatment tier), dried herb for vaporisation through a TGA-approved device or an oral capsule or liquid, a THC concentration of 25% or less, 2 grams a day or less across a maximum of three products, evidence that standard treatments were tried first, and a documented suicide and mental health assessment.

Do I need to see my prescriber in person before 31 August?

Only if you are a new client, changing prescriber, or moving to a higher treatment tier. If you are already established with an Ahpra-compliant prescriber under a DVA-funded script, the deadline itself does not force a new in-person visit.

Does this change whether I can use medicinal cannabis at all?

No. Whether medicinal cannabis is appropriate for you is a clinical decision between you and your treating doctor. This change is about the basis DVA uses to fund it, not about your right to be prescribed it.